Noncurative Resection for Gastric Cancer Patients: Who Could Benefit? : Determining Prognostic Factors for Patient Selection.

about

Noncurative Resection for Gastric Cancer Patients: Who Could Benefit? : Determining Prognostic Factors for Patient Selection.

Item

http://www.wikidata.org/entity/Q53287195

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Noncurative Resection for Gast ...... Factors for Patient Selection.

@en

Noncurative Resection for Gast ...... Factors for Patient Selection.

@nl

type

Item

label

Noncurative Resection for Gast ...... Factors for Patient Selection.

@en

Noncurative Resection for Gast ...... Factors for Patient Selection.

@nl

prefLabel

Noncurative Resection for Gast ...... Factors for Patient Selection.

@en

Noncurative Resection for Gast ...... Factors for Patient Selection.

@nl

P1476

Noncurative Resection for Gast ...... Factors for Patient Selection.

@en

P2093

Alessandro L Diniz

http://www.w3.org/2001/XMLSchema#string

André Luís de Godoy

http://www.w3.org/2001/XMLSchema#string

Antonio Moris Cury Filho

http://www.w3.org/2001/XMLSchema#string

Felipe J F Coimbra

http://www.w3.org/2001/XMLSchema#string

Héber S C Ribeiro

http://www.w3.org/2001/XMLSchema#string

Igor Correia de Farias

http://www.w3.org/2001/XMLSchema#string

Marcello Ferretti Fanelli

http://www.w3.org/2001/XMLSchema#string

Maria Dirlei F S Begnami

http://www.w3.org/2001/XMLSchema#string

Wilson Luiz da Costa

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.

A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer.

A systematic review of surgery for non-curative gastric cancer.

Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature.

Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines.

P2888

s10434-015-4945-x

P304

1212-1219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-015-4945-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fernando A. Soares

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033303559

http://www.w3.org/2001/XMLSchema#string

P698

26542593

http://www.w3.org/2001/XMLSchema#string